Welltower 超出2026年第三季度财报预期，并上调全年指引，机构关注度强劲，评级为“中度买入”。 Welltower beat Q3 2026 earnings estimates and raised full-year guidance, with strong institutional interest and a "Moderate Buy" rating.

Welltower Inc.报告收入丰厚的Q3 2026,收入为1.45 EPS和31.8亿美元,超过估计,并将2026年全年EPS指导提高到6.09至6.25美元。 Welltower Inc. reported strong Q3 2026 earnings, with $1.45 EPS and $3.18 billion in revenue, surpassing estimates, and raised its 2026 full-year EPS guidance to $6.09–$6.25. 该股票于2026年3月10日关闭207.61美元,市场上限为144.86亿美元,PE比率为148.29美元。 The stock closed at $207.61 on March 10, 2026, with a market cap of $144.86 billion and a PE ratio of 148.29. 机构所有权仍然很高,第一信托顾问的利害关系增加。 Institutional ownership remains high, with First Trust Advisors increasing its stake. 分析师维持了“机动购买”共识,目标价格为224.71美元。 Analysts maintain a "Moderate Buy" consensus and a target price of $224.71. 该公司在美国和国际上拥有医疗保健财产。 The company owns healthcare properties across the U.S. and internationally.